Pyongyang meeting seen as bolstering Xi ahead of Trump talks
Friday, 21 June 2019 23:37 WIB | GLOBAL |Global

Chinese President Xi Jinping's two-day state visit to North Korea couldn't have come at a better time for both countries, analysts say. For Pyongyang, it could help pave the way back to negotiations with the United States. For Beijing, they say, it provides Xi Jinping with a way to highlight China's influence on the North Korean nuclear issue.

One key message of Xi's visit is the claimed strength of ties between the two countries “ a narrative state media in both countries have been pushing heavily over the past two days. The Korean Central News Agency (KCNA) called the visit a œdecisive display of friendship.

KCNA said that friendship needs to be strengthened given the œserious and complex state of international relations. According to China's state-run Xinhua news agency, Xi said at a welcome banquet that the two countries had agreed to œunswervingly pass down their traditional friendship from generation to generation.

But ties between the two countries are much more tense and complex than state media reports suggest, partly explaining why Xi is the first Chinese leader to visit North Korea since 2005.

North Korea's flaunting of United Nations sanctions in the past “ including missile and nuclear tests “ has been a challenge to the relationship. Beijing has also joined the international community in imposing tough sanctions which remain in place against Pyongyang.

There has been some improvement in the relationship since the United States opened direct negotiations with the North, including President Donald Trump's high-profile summits with North Korean leader Kim Jong Un in Singapore and Hanoi. During almost the same period, Kim visited China four times.

Source : VOA News

RELATED NEWS

US, Gates Foundation Plan $200M for Sickle Cell, HIV Cures
Thursday, 24 October 2019 10:50 WIB

The U.S. government and the Bill and Melinda Gates Foundation pledged Wednesday to jointly invest $200 million over the next four years to achieve affordable gene therapy-based cures for sickle cell disease (SCD) and HIV. The administration of President Donald Trump announced earlier this year its ...

Hong Kong Legislators Formally Kill Controversial Extradition Bill
Wednesday, 23 October 2019 23:42 WIB

Hong Kong™s legislature on Wednesday formally killed the extradition bill that sparked four months of anti-government protests ” on the same day that the murder suspect at the center of this issue was released from jail in Hong Kong and said he plans to turn himself in to Taiwanese authorities. ...

US Defense Secretary Arrives in Iraq
Wednesday, 23 October 2019 16:56 WIB

U.S. Defense Mark Esper arrived in Baghdad on an unannounced visit Wednesday for talks with Iraqi officials about the arrival of U.S. troops recently withdrawn from northern Syria. Seven hundred or more troops have moved into western Iraq, where 5,000 military personnel are already deployed. Esper ...

US to Ask NATO to Pay More to Protect Saudi Arabia From Iran
Wednesday, 23 October 2019 11:07 WIB

Defense Secretary Mark Esper says he will urge allies later this week to contribute more to the defense of Saudi Arabia and the Gulf region to counter threats from Iran. The plan is part of a broader U.S. effort to get NATO allies to take on more responsibility for Gulf security. That has included ...

Japan's Emperor Naruhito Formally Declares His Ascension to Throne
Tuesday, 22 October 2019 23:43 WIB

Japan's new Emperor Naruhito formally ascended to the throne Tuesday in an elaborate ceremony in Tokyo. Naruhito read out a proclamation at the Imperial Palace, promising to fulfill his responsibility as the symbol of the state and of the unity of the people.  The brief event ended with Prime ...

ANOTHER NEWS
US, Gates Foundation Plan $200M for Sickle Cell, HIV Cures
Thursday, 24 October 2019 10:50 WIB The U.S. government and the Bill and Melinda Gates Foundation pledged Wednesday to jointly invest $200 million over the next four years to achieve affordable gene therapy-based cures for sickle cell disease (SCD) and HIV. The administration of...

DISCLAIMER

Seluruh materi atau konten yang tersaji di dalam website ini hanya bersifat informatif saja, dan tidak dimaksudkan sebagai pegangan serta keputusan dalam investasi atau jenis transaksi lainnya. Kami tidak bertanggung jawab atas segala akibat yang timbul dari penyajian konten tersebut. Semua pihak yang mengunjungi website ini harus membaca Terms of Service (Syarat dan Ketentuan Layanan) terlebih dahulu dan dihimbau untuk melakukan analisis secara independen serta memperoleh saran dari para ahli dibidangnya.